[144] Ginkgo Bioworks Holdings, Inc. SEC Filing
Rhea-AI Filing Summary
Ginkgo Bioworks (DNA) Form 144 notice: An insider notified the sale of 10,000 Class A shares through Fidelity Brokerage Services (900 Salem St, Smithfield RI) with an approximate aggregate market value of $109,209.3447,089,598 and an approximate sale date of 09/08/2025. All 10,000 shares were acquired from the issuer as restricted stock vesting on dates between 11/19/2021 and 03/11/2022 and were paid as compensation. The filer reports no securities sold in the past three months.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider plans to sell 10,000 vested Class A shares (~$109k) into the market via Fidelity on 09/08/2025.
The filing is a routine Rule 144 disclosure showing that the shares were acquired through restricted stock vesting and paid as compensation between 2021 and 2022. The total shares to be sold equal the sum of the vesting lots, indicating a disposal of previously restricted holdings rather than newly acquired shares. No prior sales by the filer in the past three months are reported, and the filing contains no material non-public disclosures.
TL;DR: This is a standard insider sale notice with acquisition history disclosed; procedural compliance appears met.
The Form 144 documents the broker, share count, market value, acquisition dates, and that payment was for compensation. It includes the required representation about material non-public information. The filing does not disclose any unusual terms or related-party transfers; it appears to be a routine disclosure under Rule 144.